Influenza B virus victoria group with a new glycosylation site was epidemic in Japan in the 2002-2003 season

Journal of Clinical Microbiology
Naoko NakagawaY Okuno

Abstract

In the 2002-2003 season, influenza B virus Victoria strains were epidemic after a 6-year absence in Kobe City, Japan. They reacted poorly to the immune ferret sera prepared for use against the previous strain. An amino acid substitution in the HA1 region caused them to acquire an N-linked glycosylation site.

References

Aug 1, 1997·The Journal of Infectious Diseases·I T Schulze
May 12, 2000·Science·A D OsterhausR A Fouchier
Aug 1, 2002·Journal of Clinical Microbiology·Naoko NakagawaKozaburo Hayashi
Mar 26, 2003·The Journal of General Virology·Naoko NakagawaYoshinobu Okuno

❮ Previous
Next ❯

Citations

Oct 9, 2008·Journal of Molecular Evolution·Baltazar NunesHelena Rebelo-de-Andrade
May 6, 2005·Journal of Clinical Microbiology·X Sherry ChiSheau-Mei Cheng
Aug 6, 2005·Journal of Clinical Microbiology·Naoko NakagawaYoshinobu Okuno
Apr 7, 2006·Journal of Clinical Microbiology·Naoko NakagawaYoshinobu Okuno
Jan 11, 2008·Journal of Virology·Qinghua WangJianpeng Ma
May 28, 2005·Journal of Virology·Elisabetta BianchiAntonello Pessi
Oct 19, 2007·Proceedings of the National Academy of Sciences of the United States of America·Qinghua WangJianpeng Ma
Dec 2, 2014·BMC Research Notes·Muhammad Raihan JumatBoon-Huan Tan
Jan 19, 2008·Journal of Virological Methods·Toshimasa NakagawaNaoko Nakagawa
Nov 26, 2008·Journal of Medical Virology·Jun ShenQinghua Wang
Dec 9, 2020·Antimicrobial Agents and Chemotherapy·Evelien VanderlindenDominique Schols

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Microbiology
Naoko NakagawaKozaburo Hayashi
Journal of Medical Virology
Pedro PechirraHelena Rebelo-de-Andrade
The Journal of General Virology
Chang-Shung TungCatherine A Macken
© 2022 Meta ULC. All rights reserved